867 related articles for article (PubMed ID: 22122739)
41. Acu-URO17 is a highly sensitive and specific bladder cancer biomarker.
Guo L; Cid A; Cucci J; Kunkel B; Defeis L; Matthews M
BJUI Compass; 2024 May; 5(5):497-501. PubMed ID: 38751950
[TBL] [Abstract][Full Text] [Related]
42. Advances in screening protocols for the detection of early bladder cancer.
Geller AC; Brooks DR; Barber CE; Koh HK; Lew RA; Wax S; Prout MN
J Occup Med; 1990 Sep; 32(9):929-35. PubMed ID: 2074522
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of URO17® to improve non-invasive detection of bladder cancer.
Porten SP; Wang EY; Vohra P; Carroll PR; Jahanfard S; Kim NW
Urol Oncol; 2024 Jun; 42(6):176.e21-176.e28. PubMed ID: 38553264
[TBL] [Abstract][Full Text] [Related]
44. Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy.
Hourigan SK; Zhu W; S W Wong W; Clemency NC; Provenzano M; Vilboux T; Niederhuber JE; Deeken J; Chung S; McDaniel-Wiley K; Trump D
BMC Urol; 2020 Jan; 20(1):5. PubMed ID: 31992287
[TBL] [Abstract][Full Text] [Related]
45. Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle-invasive bladder cancer.
Krishnatry R; Maitre P; Kumar A; Telkhade T; Bakshi G; Prakash G; Pal M; Joshi A; Menon S; Murthy V
Cancer Med; 2023 May; 12(10):11305-11314. PubMed ID: 36965102
[TBL] [Abstract][Full Text] [Related]
46. Rapid diagnostic service for patients with haematuria.
Lynch TH; Waymont B; Dunn JA; Hughes MA; Wallace DM
Br J Urol; 1994 Feb; 73(2):147-51. PubMed ID: 8131015
[TBL] [Abstract][Full Text] [Related]
47. Clinical Validation of the Proenkephalin (
Han H; Oh TJ; Heo JE; Lee J; Jang WS; Lee SH; Ham WS; Hwang J; An S; Choi YD
Eur Urol Open Sci; 2024 Apr; 62():99-106. PubMed ID: 38496823
[TBL] [Abstract][Full Text] [Related]
48. Transurethral ultrasonography, fiberoptic cystoscopy and bladder washout cytology in the evaluation of bladder tumours.
Akdaş A; Türkeri L; Ersev D; Ersev A; Kullu S
Int Urol Nephrol; 1992; 24(5):503-8. PubMed ID: 1459827
[TBL] [Abstract][Full Text] [Related]
49. A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.
Lotan Y; Daneshmand S; Shore N; Black P; Scarpato KR; Patel A; Lough T; Shoskes DA; Raman JD
J Urol; 2024 Jul; 212(1):41-51. PubMed ID: 38700731
[TBL] [Abstract][Full Text] [Related]
50. Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.
Clin B; ; Pairon JC
BMC Public Health; 2014 Nov; 14():1155. PubMed ID: 25377503
[TBL] [Abstract][Full Text] [Related]
51. Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor.
Haas M; Kriegmair MC; Breyer J; Sikic D; Wezel F; Roghmann F; Brehmer M; Wirtz RM; Jarczyk J; Erben P; Bahlinger V; Goldschmidt F; Fechner G; Chen J; Paxinos E; Bates M; Zengerling F; Bolenz C; Burger M; Hartmann A; Eckstein M
BJU Int; 2024 May; ():. PubMed ID: 38717014
[TBL] [Abstract][Full Text] [Related]
52. Follow-up of superficial bladder cancer: how to spare cystoscopies?
Vera-Donoso CD; Llopis B; Oliver F; Server G; Alonso M; Jimenez-Cruz JF
Eur Urol; 1990; 17(1):17-9. PubMed ID: 2180718
[TBL] [Abstract][Full Text] [Related]
53. Urine cytology in the detection of bladder tumor recurrence.
Orandi A; Orandi M
J Urol; 1976 Nov; 116(5):568-9. PubMed ID: 978807
[TBL] [Abstract][Full Text] [Related]
54. Investigation of adults with haematuria.
Stonelake PS; Wallace DM
BMJ; 1990 Dec; 301(6765):1396-7. PubMed ID: 2091648
[No Abstract] [Full Text] [Related]
55. Significance of the evaluation of asymptomatic microscopic haematuria in young men.
Sparwasser C; Cimniak HU; Treiber U; Pust RA
Br J Urol; 1994 Dec; 74(6):723-9. PubMed ID: 7827841
[TBL] [Abstract][Full Text] [Related]
56. The performance characteristics of the bladder tumour antigen test.
Kirollos MM; McDermott S; Bradbrook RA
Br J Urol; 1997 Jul; 80(1):30-4. PubMed ID: 9240176
[TBL] [Abstract][Full Text] [Related]
57. [The evaluation of cystoscopy in the screening of asymptomatic microhematuria].
Hattori R; Matsuura O; Takeuchi N; Hashimoto J; Ohshima S; Ono Y; Yamada S; Kinukawa T; Miyake K
Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):810-5. PubMed ID: 1875575
[TBL] [Abstract][Full Text] [Related]
58. Fractionated urinary cytology in the follow-up of bladder cancer.
Hastie KJ; Ahmad R; Moisey CU
Br J Urol; 1990 Jul; 66(1):40-1. PubMed ID: 2393798
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic contribution of bladder washing and multiple biopsies in bladder cancers.
Denis L; Nowé P; Declercq G
Eur Urol; 1980; 6(3):137-8. PubMed ID: 7371657
[TBL] [Abstract][Full Text] [Related]
60. A three centre audit of IVU referrals in patients with asymptomatic microscopic haematuria.
Rockall AG; Wetton CW; Thomas KE; Kellett MJ
Clin Radiol; 1996 Apr; 51(4):282-4. PubMed ID: 8617042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
